Meuro

SciBase Barrier technology part of major immunodermatology project

Retrieved on: 
Wednesday, March 23, 2022
Dutch Research Council, Biomarker, Skin, University, Meuro, SCIB, Research, Hospital, Data analysis, Consortium, University Medical Center Schleswig Holstein, Disease management, NWO, Atopic dermatitis, Patient, Pharmaceutical industry, Dermatology

NGID is a nationwide, large-scale project to unravel novel biomarkers for six different skin diseases.

Key Points: 
  • NGID is a nationwide, large-scale project to unravel novel biomarkers for six different skin diseases.
  • The importance of the skin barrier in diseases such as atopic dermatitis is well known, but until now it has not been possible to evaluate the barrier in routine clinical practice.
  • The inclusion of these SciBase products in this consortium is a testament to the robust diagnostic potential of the SciBase technology.
  • The opportunity for SciBase is to become an integral part of personalized atopic dermatitis management, and with the very high numbers of patients affected, this is one of the most significant opportunities for SciBase to date", says Simon Grant CEO SciBase.